SAB Biotherapeutics, Inc.
SABS
$3.94
-$0.21-5.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 365.27% | 264.73% | -84.69% | -70.83% | -63.30% |
| Total Receivables | 1,621.45% | 477.32% | -- | -88.92% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.03% | -9.96% | 77.12% | 26.80% | 27.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 324.73% | 248.15% | -76.48% | -65.29% | -59.61% |
|
|
|||||
| Total Current Assets | 324.73% | 248.15% | -76.48% | -65.29% | -59.61% |
| Net Property, Plant & Equipment | -2.59% | -6.30% | -6.36% | -5.55% | -19.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,032.44% | -75.87% | -19.97% | -18.81% | 37.66% |
| Total Assets | 291.01% | 241.00% | -51.32% | -46.59% | -47.35% |
|
|
|||||
| Total Accounts Payable | 85.63% | 127.83% | 123.89% | 103.27% | 79.16% |
| Total Accrued Expenses | 20.30% | -0.43% | 40.31% | 17.03% | -18.22% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.20% | 88.36% | -20.51% | -28.80% | -56.19% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 33.86% | 22.43% | 41.38% | 16.24% | -26.21% |
|
|
|||||
| Total Current Liabilities | 33.86% | 22.43% | 41.38% | 16.24% | -26.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 29.61% | 30.12% | 32.06% | 44.88% | -4.86% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -11.80% | -41.67% | -51.57% | -78.54% | -45.74% |
| Total Liabilities | 16.95% | 8.76% | 14.84% | -9.90% | -31.59% |
|
|
|||||
| Common Stock & APIC | 71.84% | 70.52% | 1.91% | 1.90% | 1.92% |
| Retained Earnings | 10.69% | 16.62% | -36.18% | -36.05% | -37.87% |
| Treasury Stock & Other | 5.69% | 0.35% | 0.28% | -0.86% | -2.95% |
| Total Common Equity | 483.35% | 347.32% | -73.95% | -59.47% | -54.68% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 483.35% | 347.32% | -73.95% | -59.47% | -54.68% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 483.35% | 347.32% | -73.95% | -59.47% | -54.68% |
|
|
|||||